Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Research & Discovery » Proteomics & Protein Research » Digilab, BioVisioN, Invitrogen, Bruker, Biacore, Bio-Rad, Thermo Electron, LabCorp, Yale, BSI, AstraZeneca, NE BioGroup, Nonlinear

Digilab, BioVisioN, Invitrogen, Bruker, Biacore, Bio-Rad, Thermo Electron, LabCorp, Yale, BSI, AstraZeneca, NE BioGroup, Nonlinear

Mar 02, 2006
Premium

Digilab Acquires BioVisioN to Develop Disease-Management Products

Digilab announced this week that it has acquired peptide-profiler BioVisioN.

"We plan to integrate proprietary Digilab tools into research processes and ultimately disease management systems," said Digilab President David Giddings in a statement.

Financial details were not released.

BioVisioN patented the Peptidomics technology and Differential Peptide Display software for peptide biomarker discovery. It is based in Hannover, Germany.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

NSF's Investigations

Nature News reports on the US National Science Foundation's investigations of undisclosed foreign ties among researchers it funds.

OK, So Who Is Here?

Researchers have developed a set of 10 principles to guide how a list of all species on earth should be put together, the Guardian reports.

Write It In

Wired reports on a new firm developing a gene writing approach for therapeutic genome changes.

Nature Presents Approach to Uncover Regulatory Noncoding Variants in Cancer, More

In Nature this week: a method called cis-X combines whole-genome and transcriptome sequencing data to identify regulatory noncoding variants, and more.

What's Popular?

In Proteomics & Protein Research

  1. Twist Bioscience, Takeda Pharma Partner to Develop Antibodies for Oncology, Rare Diseases

  2. WuXi NextCode, Olink Ink Agreement to Provide Proteomic Assays in China

  3. Integrated Proteomic Papers Define Lung Cancer Features Across Populations, Smoking Histories

  4. Cancer Research UK, Abcam Partner to Develop Custom Antibodies for Cancer Research

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.